Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +20.32%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.82%
#5 Mubarak Mubarak +18.55%
#6 Wrapped POL Wrapped POL +17.43%
#7 POL (ex-MATIC) POL (ex-MATIC) +17.16%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +16.13%
#9 Unit Pump Unit Pump +11.46%
#10 Pump.fun Pump.fun +11.46%
Coin of the day
Official Trump Official Trump
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Rang in Aktien #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Aktienkurs
$3.78
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$71.20M
Veränderung (1 Tag)
2.24%
Veränderung (1 Jahr)
-43.37%
Land
FR
Handel MaaT Pharma S.A. (MAAT)

Kategorie

Healthcare
Kursverlauf für MaaT Pharma S.A. (MAAT)
Höchster Schlusskurs: $3.53 am 2026-08-01

Niedrigster Schlusskurs: $15.22 am 2021-11-01
Kursverlauf der Aktie von MaaT Pharma S.A. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH